VentriPoint Diagnostics Ltd VPTDF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.07
- Day Range
- $0.06–0.06
- 52-Week Range
- $0.06–0.14
- Bid/Ask
- $0.04 / $0.07
- Shares Outstanding
- 192.88M
- Market Cap
- $11.73M
- Volume/Avg
- 31,200 / 120,912
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 104.21
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.ventripoint.com
Valuation
|
Metric
|
VPTDF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 104.21 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VPTDF
|
|---|---|
Quick Ratio | 0.09 |
Current Ratio | 0.12 |
Interest Coverage | −3.27 |
Quick Ratio
VPTDF
Profitability
|
Metric
|
VPTDF
|
|---|---|
Return on Assets (Normalized) | −463.18% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
VPTDF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|lP&H%D | LOCK|HHP$ | $177B | |||
| Medtronic PLC
MDT
| LOCK|Rt$!PS | LOCK|JVQ?$ | $124B | |||
| Stryker Corp
SYK
| LOCK|%VLTXF!z | LOCK|&$C | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|NVw%<d | LOCK|qSN? | $67B | |||
| Edwards Lifesciences Corp
EW
| LOCK|X&v<sh#^ | LOCK|tZ$Z | $52B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|ZLXM$@ | LOCK|$!$ | $32B | |||
| DexCom Inc
DXCM
| LOCK|x^jZK@! | LOCK|#FB! | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|d< | LOCK|yqt | $26B | |||
| Steris PLC
STE
| LOCK|%k$NV#^ | LOCK|B%mn | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|fZP$v&q | LOCK|MV& | $19B |
United States